In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, May 2015

Executive Summary

This Month's Profile Group, Cancer Immunotherapy, features profiles of Annias Immunotherapeutics, Costanoan Immunotherapies, and Unum Therapeutics. Plus these Start-Ups Across Health Care: Glyconics, Metactive Medical, and Navigate Surgical Technologies

You may also be interested in...

Glyconics Ltd.

Chronic obstructive pulmonary disease remains a particularly difficult disease to accurately diagnose, with little improvement over the last 30 years. UK-based Glyconics Ltd. hopes to reliably detect COPD with an easy, five-minute, in-office procedure that uses a sputum sample to identify a handful of proprietary biomarkers specific for the disease.

Metactive Medical Inc.

Metactive Medical Inc. has developed two endovascular devices that provide immediate and long-term sealing of an aneurysm or a blood vessel. Both devices – Ballstent Microcatheter (neurovascular) and Blockstent Microcatheter (peripheral vascular) – implant an inflatable gold metal balloon using an over-the-wire microcatheter.

Navigate Surgical Technologies Inc.

The percentage of dentists placing dental implants could increase substantially in the coming months and years, thanks in part to a real-time, cone beam computed tomography (CBCT) guided surgical navigation system scaled to an accessible level for a general practitioner. Inliant Clinical from Navigate Surgical Technologies Inc. uses optical motion tracking to increase drilling accuracy and streamline procedure workflows.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts